BrainCo Files for Hong Kong IPO to Raise Capital for BCI Expansion
BrainCo, a prominent Chinese developer of non-invasive brain-computer interface (BCI) technology, has confidentially filed for an initial public offering (IPO) in Hong Kong, according to reports from Bloomberg. The company, often cited as a rival to US-based Neuralink, distinguishes itself by utilizing non-implantable BCI solutions. Sources indicate that the upcoming listing aims to raise several hundred million dollars, with major financial institutions CICC and UBS Group managing the share sale. Founded in 2015, BrainCo is recognized as part of the "Hangzhou Six," a notable group of emerging tech startups from Hangzhou that also includes AI firm DeepSeek. This IPO filing follows a significant financing round where the company secured approximately 2 billion yuan ($287 million), co-led by IDG Capital and Walden International. The move underscores the growing investor interest in the BCI sector and highlights the competitive landscape between Chinese and American tech firms in advanced neurotechnology. By going public in Hong Kong, BrainCo seeks to capitalize on market opportunities and further develop its proprietary technologies without the surgical requirements associated with competitors like Neuralink.
Wire timeline
BrainCo Files for Hong Kong IPO to Raise Capital for BCI Expansion
BrainCo, a prominent Chinese developer of non-invasive brain-computer interface (BCI) technology, has confidentially filed for an initial public offering (IPO) in Hong Kong, according to reports from Bloomberg. The company, often cited as a rival to US-based Neuralink, distinguishes itself by utilizing non-implantable BCI solutions. Sources indicate that the upcoming listing aims to raise several hundred million dollars, with major financial institutions CICC and UBS Group managing the share sale. Founded in 2015, BrainCo is recognized as part of the "Hangzhou Six," a notable group of emerging tech startups from Hangzhou that also includes AI firm DeepSeek. This IPO filing follows a significant financing round where the company secured approximately 2 billion yuan ($287 million), co-led by IDG Capital and Walden International. The move underscores the growing investor interest in the BCI sector and highlights the competitive landscape between Chinese and American tech firms in advanced neurotechnology. By going public in Hong Kong, BrainCo seeks to capitalize on market opportunities and further develop its proprietary technologies without the surgical requirements associated with competitors like Neuralink.
TechNode